Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status

Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status Yu-Tang Chin1,2†, Zong-Rong He3,4†, Chi-Long Chen5†, Hsiao-Ching Chu6, Yih Ho1,7, Po-Yu Su8, Yu-Chen S. H. Yang9, Kuan Wang1,8, Ya-Jung Shih1,8, Yi-Ru Chen1,8, Jens Z. Pedersen10, Sandra Incerpi11, André Wendindondé Nana12, Heng-Yuan Tang13, Hung-Yun Lin1,12,13,14,15*, Shaker A. Mousa13, Paul J. Davis13,16 and Jacqueline Whang-Peng1,2,12* 1Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan 2Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan 3Department of Pediatrics, E-Da Hospital, Kaohsiung, Taiwan 4School of Medicine, I-Shou University, Kaohsiung, Taiwan 5School of Medicine, Taipei Medical University, Taipei, Taiwan 6Division of Medical Imaging, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan 7School of Pharmacy, Taipei Medical University, Taipei, Taiwan 8Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan 9Joint Biobank, Office of Human Research, Taipei Medical University, Taipei, Taiwan 10Department of Biology, University of Rome Tor Vergata, Rome, Italy 11Department of Sciences, Roma Tre University, Rome, Italy 12Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, T...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research